Prognostic factors in oral and oropharyngeal cancer based on ultrastructural analysis and DNA methylation of the tumor and surgical margin

Tumor Biology

Volumn 35, Issue 8, 2014, Pages 7441-7449

  Mielcarek Kuchta, Daniela ^a   Paluszczak, Jarosław ^a   Seget, Monika ^a   Kiwerska, Katarzyna ^b   Biczysko, Wiesława ^a   Szyfter, Krzysztof ^a,b   Szyfter, Witold ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b POLISH ACADEMY OF SCIENCES   (Poland)

Author keywords

Methylation; Oral cancer; Prognostic factors; Ultrastructural examination

Indexed keywords

ACID ANHYDRIDE HYDROLASE; FRAGILE HISTIDINE TRIAD PROTEIN; TUMOR PROTEIN;

ADULT; AGED; CANCER STAGING; DNA METHYLATION; FEMALE; GENETICS; HUMAN; MALE; MIDDLE AGED; MORTALITY; MOUTH TUMOR; OROPHARYNX TUMOR; PATHOLOGY; PROGNOSIS; PROSPECTIVE STUDY; TUMOR SUPPRESSOR GENE; ULTRASTRUCTURE; VERY ELDERLY;

ACID ANHYDRIDE HYDROLASES; ADULT; AGED; AGED, 80 AND OVER; DNA METHYLATION; FEMALE; GENES, P16; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM PROTEINS; NEOPLASM STAGING; OROPHARYNGEAL NEOPLASMS; PROGNOSIS; PROSPECTIVE STUDIES;

EID: 84922393422     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1007/s13277-014-1958-1     Document Type: Article

References (56)

1. Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 2009;45(4–5):309–16.
2. Warnakulasuriya S. Causes of oral cancer—an appraisal of controversies. Br Dent J. 2009;207(10):471–5.
3. Soudry E, Preis M, Hod R, Hamzany Y, Hadar T, et al. Squamous cell carcinoma of the oral tongue in patients younger than 30 years: clinicopathologic features and outcome. Clin Otolaryngol. 2010;35(4):307–12.
4. Curado MP, Hashibe M. Recent changes in the epidemiology of head and neck cancer. Curr Opin Oncol. 2009;21(3):194–200.
5. Gawecki W, Szyfter K, Szyfter W. Clinical and histopathological analysis of squamous cell carcinoma of the head and neck in young adults. Otolaryngol Pol. 2007;61(1):11–6.
6. Gawecki W, Kostrzewska-Poczekaj M, Gajecka M, Milecki P, Szyfter K, et al. The role of genetic factor in etiopathogenesis of squamous cell carcinoma of the head and neck in young adults. Eur Arch Otorhinolaryngol. 2007;264(12):1459–65.
7. Mielcarek-Kuchta D, Wierzbicka M, Mietkiewska D, Kopec T, Banaszewski J, et al. Retrospective analysis of the treatment failure of the oral cancer in Department of Otolaryngology and Clinical Oncology University of Medical Sciences in Poznan in the year 2000–2005. Otolaryngol Pol. 2011;65(1):26–32.
8. Klussmann JP, Preuss SF, Speel EJ. Human papillomavirus and cancer of the oropharynx. Molecular interaction and clinical implications. HNO. 2009;57(2):113–22.
9. Klussmann JP, Mooren JJ, Lehnen M, Claessen SM, Stenner M, et al. Genetic signatures of HPV-related and unrelated oropharyngeal carcinoma and their prognostic implications. Clin Cancer Res. 2009;15(5):1779–86.
10. Hafkamp HC, Manni JJ, Haesevoets A, Voogd AC, Schepers M, et al. Marked differences in survival rate between smokers and nonsmokers with HPV 16-associated tonsillar carcinomas. Int J Cancer. 2008;122(12):2656–64.
11. Ragin CC, Taioli E. Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis. Int J Cancer. 2007;121(8):1813–20.
12. Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer. 1953;6(5):963–8.
13. Califano J, van der Riet P, Westra W, Nawroz H, Clayman G, et al. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res. 1996;56(11):2488–92.
14. Braakhuis BJ, Tabor MP, Kummer JA, Leemans CR, Brakenhoff RH. A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res. 2003;63(8):1727–30.
15. Hecht SS. Cigarette smoking and lung cancer: chemical mechanisms and approaches to prevention. Lancet Oncol. 2002;3(8):461–9.
16. Wiencke JK. DNA adduct burden and tobacco carcinogenesis. Oncogene. 2002;21(48):7376–91.
17. Esteller M. Epigenetic gene silencing in cancer: the DNA hypermethylome. Hum Mol Genet. 2007;16(1):R50–9.
18. Ha PK, Califano JA. Promoter methylation and inactivation of tumour-suppressor genes in oral squamous-cell carcinoma. Lancet Oncol. 2006;7(1):77–82.
19. Rodriguez-Paredes M, Esteller M. Cancer epigenetics reaches mainstream oncology. Nat Med. 2011;17(3):330–9.
20. Sinha P, Bahadur S, Thakar A, Matta A, Macha M, et al. Significance of promoter hypermethylation of p16 gene for margin assessment in carcinoma tongue. Head Neck. 2009;31(11):1423–30.
21. Shaw RJ, Hall GL, Woolgar JA, Lowe D, Rogers SN, et al. Quantitative methylation analysis of resection margins and lymph nodes in oral squamous cell carcinoma. Br J Oral Maxillofac Surg. 2007;45(8):617–22.
22. Chang HW, Chow V, Lam KY, Wei WI, Yuen A. Loss of E-cadherin expression resulting from promoter hypermethylation in oral tongue carcinoma and its prognostic significance. Cancer. 2002;94(2):386–92.
23. Ai L, Vo QN, Zuo C, Li L, Ling W, et al. Ataxia-telangiectasia-mutated (ATM) gene in head and neck squamous cell carcinoma: promoter hypermethylation with clinical correlation in 100 cases. Cancer Epidemiol Biomarkers Prev. 2004;13(1):150–6.
24. McGregor F, Muntoni A, Fleming J, Brown J, Felix DH, et al. Molecular changes associated with oral dysplasia progression and acquisition of immortality: potential for its reversal by 5-azacytidine. Cancer Res. 2002;62(16):4757–66.
25. Hsu HS, Chen TP, Hung CH, Wen CK, Lin RK, et al. Characterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in plasma. Cancer. 2007;110(9):2019–26.
26. Gronbaek K, Worm J, Ralfkiaer E, Ahrenkiel V, Hokland P, et al. ATM mutations are associated with inactivation of the ARF-TP53 tumor suppressor pathway in diffuse large B-cell lymphoma. Blood. 2002;100(4):1430–7.
27. King-Batoon A, Leszczynska JM, Klein CB. Modulation of gene methylation by genistein or lycopene in breast cancer cells. Environ Mol Mutagen. 2008;49(1):36–45.
28. Smith JA, Fan CY, Zou C, Bodenner D, Kokoska MS. Methylation status of genes in papillary thyroid carcinoma. Arch Otolaryngol Head Neck Surg. 2007;133(10):1006–11.
29. Huang Q. A.L., Zhang ZY, Fan CY, Weiss LM., Promoter hypermethylation and protein expression of the p16 gene: analysis of 43 cases of B-cell primary gastric lymphomas from China. Mod Pathol. 2004;17(4):416–22.
30. Yokota J, Kohno T. Molecular footprints of human lung cancer progression. Cancer Sci. 2004;95(3):197–204.
31. Kannan S, Kartha CC, Chandran GJ, Pillai MR, Sudha L, et al. Ultrastructure of oral squamous cell carcinoma: a comparative analysis of different histological types. Eur J Cancer B Oral Oncol. 1994;30B(1):32–42.
32. Cheng LH, Hudson J. Ultrastructural changes in malignant transformation of oral mucosa. Br J Oral Maxillofac Surg. 2002;40(3):207–12.
33. Kannan S, Kartha CC, Balaram P, Chandran GJ, Pillai MR, et al. Ultrastructural analysis of the adjacent epithelium of oral squamous cell carcinoma. Br J Oral Maxillofac Surg. 1996;34(1):51–7.
34. Kurita H, Nakanishi Y, Nishizawa R, Xiao T, Kamata T, et al. Impact of different surgical margin conditions on local recurrence of oral squamous cell carcinoma. Oral Oncol. 2010;46(11):814–7.
35. Spiro RH, Guillamondegui Jr O, Paulino AF, Huvos AG. Pattern of invasion and margin assessment in patients with oral tongue cancer. Head Neck. 1999;21(5):408–13.
36. McMahon J, O'Brien CJ, Pathak I, Hamill R, McNeil E, et al. Influence of condition of surgical margins on local recurrence and disease-specific survival in oral and oropharyngeal cancer. Br J Oral Maxillofac Surg. 2003;41(4):224–31.
37. Upile T, Fisher C, Jerjes W, El Maaytah M, Searle A, et al. The uncertainty of the surgical margin in the treatment of head and neck cancer. Oral Oncol. 2007;43(4):321–6.
38. Binahmed A, Nason RW, Abdoh AA. The clinical significance of the positive surgical margin in oral cancer. Oral Oncol. 2007;43(8):780–4.
39. Woolgar JA. Histopathological prognosticators in oral and oropharyngeal squamous cell carcinoma. Oral Oncol. 2006;42(3):229–39.
40. Esteller M. Cancer epigenomics: DNA methylomes and histone-modification maps. Nat Rev Genet. 2007;8(4):286–98.
41. Feinberg AP. Cancer epigenetics is no Mickey Mouse. Cancer Cell. 2005;8(4):267–8.
42. Weiss D, Stockmann C, Schrodter K, Rudack C. Protein expression and promoter methylation of the candidate biomarker TCF21 in head and neck squamous cell carcinoma. Cell Oncol (Dordr). 2013;36(3):213–24.
43. Nagata S, Hamada T, Yamada N, Yokoyama S, Kitamoto S, et al. Aberrant DNA methylation of tumor-related genes in oral rinse: a noninvasive method for detection of oral squamous cell carcinoma. Cancer. 2012;118(17):4298–308.
44. Dong Y, Wang J, Dong F, Wang X, Zhang Y. The correlations between alteration of p16 gene and clinicopathological factors and prognosis in squamous cell carcinomas of the buccal mucosa. J Oral Pathol Med. 2012;41(6):463–9.
45. Roh JL, Wang XV, Manola J, Sidransky D, Forastiere AA, et al. Clinical correlates of promoter hypermethylation of four target genes in head and neck cancer: a cooperative group correlative study. Clin Cancer Res. 2013;19(9):2528–40.
46. de Freitas Cordeiro-Silva M. E. Stur, L.P. Agostini, J.R. de Podesta, J.C. de Oliveira, et al., Promoter hypermethylation in primary squamous cell carcinoma of the oral cavity and oropharynx: a study of a Brazilian cohort. Mol Biol Rep. 2012;39(12):10111–9.
47. Shaw RJ, Liloglou T, Rogers SN, Brown JS, Vaughan ED, et al. Promoter methylation of P16, RARbeta, E-cadherin, cyclin A1 and cytoglobin in oral cancer: quantitative evaluation using pyrosequencing. Br J Cancer. 2006;94(4):561–8.
48. Veganzones-de-Castro S, Rafael-Fernandez S, Vidaurreta-Lazaro M. V. de-la-Orden, B. Mediero-Valeros, et al., p16 gene methylation in colorectal cancer patients with long-term follow-up. Rev Esp Enferm Dig. 2012;104(3):111–7.
49. Tanaka H, Shimada Y, Harada H, Shinoda M, Hatooka S, et al. Methylation of the 5' CpG island of the FHIT gene is closely associated with transcriptional inactivation in esophageal squamous cell carcinomas. Cancer Res. 1998;58(15):3429–34.
50. Paluszczak J, Misiak P, Wierzbicka M, Wozniak A, Baer-Dubowska W. Frequent hypermethylation of DAPK, RARbeta, MGMT, RASSF1A and FHIT in laryngeal squamous cell carcinomas and adjacent normal mucosa. Oral Oncol. 2011;47(2):104–7.
51. Paluszczak J, Krajka-Kuzniak V, Malecka Z, Jarmuz M, Kostrzewska-Poczekaj M, et al. Frequent gene hypermethylation in laryngeal cancer cell lines and the resistance to demethylation induction by plant polyphenols. Toxicol In Vitro. 2011;25(1):213–21.
52. He Y, Chen Q, Li B. ATM in oral carcinogenesis: association with clinicopathological features. J Cancer Res Clin Oncol. 2008;134(9):1013–20.
53. Shaw RJ, Hobkirk AJ, Nikolaidis G, Woolgar JA, Triantafyllou A, et al. Molecular staging of surgical margins in oral squamous cell carcinoma using promoter methylation of p16(INK4A), cytoglobin, E-cadherin, and TMEFF2. Ann Surg Oncol. 2013;20(8):2796–802.
54. Bradley PJ, MacLennan K, Brakenhoff RH, Leemans CR. Status of primary tumour surgical margins in squamous head and neck cancer: prognostic implications. Curr Opin Otolaryngol Head Neck Surg. 2007;15(2):74–81.
55. Rodrigo JP, Ferlito A, Suarez C, Shaha AR, Silver CE, et al. New molecular diagnostic methods in head and neck cancer. Head Neck. 2005;27(11):995–1003.
56. Braakhuis BJ, Bloemena E, Leemans CR, Brakenhoff RH. Molecular analysis of surgical margins in head and neck cancer: more than a marginal issue. Oral Oncol. 2010;46(7):485–91.